International Affairs Committee
From the three perspectives of international expansion, international harmonization, and contribution to global health, the International Committee deepens cooperation with regulatory authorities, pharmaceutical organizations, and the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) in various countries and conducts activities to resolve international issues faced by the industry and member companies.
Notices and Updates
-
Pharmaceutical Industrial Policy Committee International Affairs Committee
We have posted “On Institutional Measures to Ensure a Stable Supply of Medicines and Other Products Necessary for Infectious Disease Control and to Promote Antimicrobial Drug Discovery.”
-
International Affairs Committee
We have posted an article titled “Side Event Report — 79th World Health Assembly (WHA79)”
-
International Affairs Committee
Creating the Future of Medical Care with Asia: Japan's Contribution to the Collaboration with Bac Mai Hospital (Vietnam)
-
International Affairs Committee
Report on "The 5th Japan-Vietnam Joint Symposium" is now available.
-
International Affairs Committee
Pathways from Development to Access to Innovation (IDAP)" is now available.
International Affairs Committee Content
-
Implementation Plan
The implementation plan for this fiscal year is posted.
-
Global Health
Information on Global Health.
-
STOP AMR
JPMA's activities against drug resistance (AMR) are posted.
-
Statements
JPMA's statement is posted.
-
DATA (Members only)
Back issues of international news and research materials are posted.
-
Announcement from International Affairs Committee
Various announcements from the International Affairs Committee are posted.
-
Action Fund for Drug Resistance (AMR)
JPMA contributes to the establishment of this fund as an IFPMA member organization and promotes advocacy.